BioSpace News Archive

Drug Development

Chinook Therapeutics Announces First Patient Enrolled in Pivotal Phase 3 BEYOND Study of Zigakibart (BION-1301) for Patients with IgA Nephropathy

Chinook Therapeutics, Inc. today announced that the first patient with IgA nephropathy (IgAN) has been enrolled in the BEYOND study, a pivotal phase 3 clinical trial evaluating the safety and efficacy of zigakibart (BION-1301), a potentially disease-modifying anti-APRIL monoclonal antibody.

July 28, 2023
·
10 min read
Business

Semler to Report Second Quarter 2023 Financial Results and Host Conference Call on August 10, 2023

Semler Scientific, Inc. today announced that it will report financial results for the second quarter ended June 30, 2023 , after the close of U.S. financial markets on Thursday, August 10, 2023.

July 28, 2023
·
2 min read
Drug Development

Phyllodulcin Could be a Potential Candidate for Treating Alzheimer’s Disease, Find Sahmyook University Researchers

Alzheimer’s disease (AD) is the most common neurodegenerative disorder in the world, associated with symptoms like memory loss and cognitive impairment. Brain lesions caused by the aggregation of amyloid β (Aβ) and neurofibrillary tangles are believed to be the main cause of AD.

July 28, 2023
·
3 min read
Business

Beauty-Stem Biomedical Holds Successful CD34 Stem Cell Medical Symposium Exploring Regenerative Trend ‘CD34 Health Deposit’

Ryan Huang, CEO of Beauty-Stem Biomedical, and Dr. David Chen, director of Diagnostic Medical Group of Southern California, delivered a compelling presentation highlighting the numerous benefits of CD34 stem cells.

July 28, 2023
·
2 min read
Fiber-coupled LEDs Provide High Brightness Ranging from the DUV to the NIR for Researchers and OEMs in Medical, Biotech, and Industrial Applications

LumeDEL LLC introduces the NewDEL™ Fiber-coupled LED sources that are designed to generate high radiant power with spectrally stable output and combining high performance

July 28, 2023
·
1 min read
Policy

Navidea Biopharmaceuticals, Inc. Announces NYSE American Has Commenced Delisting Proceedings and Intent to Appeal NYSE American Determination

Navidea Biopharmaceuticals, Inc. received written notification from NYSE American LLC stating that the staff of NYSE Regulation has determined to commence proceedings to delist the common stock of Navidea Biopharmaceuticals, Inc. — ticker symbol NAVB —from the Exchange.

July 28, 2023
·
5 min read
Job Trends

Press Release: Solid Q2 performance and strong pipeline momentum, Full-year 2023 business EPS guidance raised

Vaccines up 9.1% due to strong PPH vaccines sales in Rest of World region and COVID vaccine supply in Europe.

July 28, 2023
·
3 min read
Deals

Press Release: Sanofi to acquire Qunol®, a fast-growing U.S. brand in the healthy aging segment

Paris, July28, 2023. Sanofi announces it has entered into a definitive agreement to acquire ownership of Qunol®, a U.S.-based, market-leading brand in health & wellness.

July 28, 2023
·
6 min read
Business

Press release: Online availability of Sanofi’s half-year financial report for 2023

Sanofi announces that its half-year financial report for the period ending June 30, 2023 is now available and has been filed with the French market regulator Autorité des marchés financiers and submitted to the U.S. Securities and Exchange Commission under form 6-K.

July 28, 2023
·
1 min read